Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

被引：16
|
作者：
Anagnostou, Valsamo
Smith, Kellie N.
Forde, Patrick M.
Niknafs, Noushin
Bhattacharya, Rohit
White, James
Adleff, Vilmos
Phallen, Jillian
Wali, Neha
Hruban, Carolyn
Guthrie, Violeta B.
Rodgers, Kristen
Naidoo, Jarushka
Kang, Hyunseok
Sharfman, William
Georgiades, Christos
Verde, Franco
Illei, Peter
Li, Qing Ka
Gabrielson, Edward
Brock, Malcolm
Zahnow, Cynthia
Baylin, Stephen B.
Scharpf, Rob
Brahmer, Julie R.
Karchin, Rachel
Pardoll, Drew M.
Velculescu, Victor E.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-NG01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NG01
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
    Parisi, Claudia
    Lamberti, Giuseppe
    Zompatori, Maurizio
    Gelsomino, Francesco
    Salvagni, Stefania
    Sperandi, Francesca
    Ardizzoni, Andrea
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [22] Superior efficacy of neoadjuvant compared to adjuvant immune checkpoint blockade in non-small cell lung cancer
    Cascone, Tina
    Hamdi, Haifa
    Zhang, Fahao
    Poteete, Alissa
    Li, Lerong
    Hudgens, Courtney W.
    Williams, Leila J.
    Wu, Qiuyu
    Gudikote, Jayanthi
    Peng, Weiyi
    Hwu, Patrick
    Wang, Jing
    Tetzlaff, Michael
    William, William N.
    Heymach, John V.
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Generalization and representativeness of phase III immune checkpoint blockade trials in non-small cell lung cancer
    Yoo, Shin Hye
    Keam, Bhumsuk
    Kim, Miso
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    THORACIC CANCER, 2018, 9 (06) : 736 - 744
  • [24] PTPRD: A Positive Predictive Biomarker for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
    Shen, J.
    Zhou, H.
    Liu, J.
    Zhang, Y.
    Zhou, T.
    Hong, S.
    Zhao, Y.
    Yang, Y.
    Zhao, H.
    Huang, Y.
    Fang, W.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S335 - S336
  • [25] CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer
    Lau, Asa P. Y.
    Binstock, Sharon S. Khavkine
    Thu, Kelsie L.
    CANCERS, 2023, 15 (21)
  • [26] The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
    Ren, Sijia
    Xiong, Xinxin
    You, Hua
    Shen, Jianfei
    Zhou, Penghui
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
    Jiang, Zedong
    Zhou, Yao
    Huang, Juan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient
    Horio, Yuko
    Takamatsu, Koutaro
    Tamanoi, Daisuke
    Sato, Ryo
    Saruwatari, Koichi
    Ikeda, Tokunori
    Nakane, Shunya
    Nakajima, Makoto
    Saeki, Sho
    Ichiyasu, Hidenori
    Fujii, Kazuhiko
    Tomita, Yusuke
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (10) : 1764 - 1767
  • [29] Early shifts in immune cell subsets to predict response to immune checkpoint blockade in non-small cell lung cancer (NSCLC).
    Rosner, Samuel
    Forde, Patrick M.
    Naidoo, Jarushka
    Marrone, Kristen
    Reuss, Joshua E.
    Feliciano, Josephine Louella
    Levy, Benjamin Philip
    Hann, Christine L.
    Velculescu, Victor E.
    Brahmer, Julie R.
    Anagnostou, Valsamo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [30] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
12345